Flesinoxan is used as an antihypertensive agent; it exhibits potent anxiolytic and antidepressant effects through its action as a selective and high-affinity 5-HT1A receptor agonist (EC50 = 24 nM). It acts as a partial agonist at postsynaptic and a full agonist at presynaptic 5-HT1A receptors. Flesinoxan suppresses the firing activity of CA3 pyramidal neurons and dorsal raphe 5-HT neurons, and induces dose-dependent hypothermia upon subcutaneous administration.